Novartis India Profile
Key Indicators
- Authorised Capital ₹ 32.00 Cr
- Paid Up Capital ₹ 12.35 Cr
- Company Age 77 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 257.48 Cr
- Revenue Growth 0.88%
- Profit Growth 2878.49%
- Ebitda 140.06%
- Net Worth 12.14%
- Total Assets 2.65%
About Novartis India
Novartis India Limited (NIL) was founded in India on 13 December 1947 and has a glorious history of 77 years and five months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500672 and on the National Stock Exchange(NSE) under NOVARTIND.
The Corporate was formerly known as Ciba (India) Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 32.00 Cr and a paid-up capital of Rs 12.35 Cr.
The company has closed loans amounting to ₹257.48 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Novartis India Limited India are Shilpa Joshi as CFO and Chandni Maru as Company Secretary. Falin Majmudar, Sandra Martyres, Christopher Snook, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
Pharma
What products or services does Novartis India Limited offer?
Novartis India Limited offers a wide range of products and services, including Immunity Boosters, Antioxidant Supplements, Vitamins & Supplements, Vitamins A-Z, Mineral Supplements, Nutritional Drinks, For Adults, Health Conditions, Pain Relief, Bone, Joint & Muscle Care.
Novartis India Limited
Explore comprehensive data for Novartis India Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Novartis India?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shilpa Joshi  | CFO | 22-Nov-2022 | Current |
| Chandni Maru | Company Secretary | 20-May-2024 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanker Parameswaran | Director | 22-Jun-2020 | Current |
| Sandra Martyres | Director | 19-Apr-2016 | Current |
| Gira Sardesai | Director | 31-Mar-2024 | Current |
| Falin Majmudar | Whole-Time Director | 28-Jun-2024 | Current |
Christopher Snook  | Director | 01-Aug-2008 | Current |
| Shilpa Joshi | Whole-Time Director and Cfo | 22-Nov-2022 | Current |
Financial Performance of Novartis India.
Novartis India Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.88% increase. The company also saw a substantial improvement in profitability, with a 2878.49% increase in profit. The company's net worth Soared by an impressive increase of 12.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novartis India?
In 2023, Novartis India had a promoter holding of 70.68% and a public holding of 29.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Balaji Valve Components LimitedSanker Parameswaran is a mutual person
Novartis Comprehensive Leprosy Care AssociationShilpa Joshi is a mutual person
Ica Pidilite Private LimitedGira Sardesai is a mutual person
Franklin Templeton Trustee Services Private LimitedSandra Martyres is a mutual person
Hni Office India LimitedSandra Martyres is a mutual person
Daystar Travels Private LimitedSandra Martyres is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹257.48 Cr
Charges Breakdown by Lending Institutions
- Grindlays Bank : 111.60 Cr
- Allahabad Bank : 45.00 Cr
- Bnp Paribas : 33.00 Cr
- Nationale De Paris French Bank Building : 32.50 Cr
- The Industrial Credit And Investment Corpn. Of India Ltd. : 20.00 Cr
- Others : 15.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 1999 | Bnp Paribas | ₹33.00 Cr | Satisfied |
| 02 May 1998 | The Hongkong And Shanghai Banking Corporation Ltd. | ₹5.00 Cr | Satisfied |
| 21 Jul 1993 | Grindlays Bank | ₹45.00 Cr | Satisfied |
| 21 Jul 1993 | Allahabad Bank | ₹45.00 Cr | Satisfied |
| 28 May 1992 | Grindlays Bank | ₹38.00 Cr | Satisfied |
How Many Employees Work at Novartis India?
Novartis India has a workforce of 59 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novartis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novartis India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Novartis India
Recent activity within the organization
- Charges
A charge registered on 06 Aug 1940 via Charge ID 90230132 with The National Bank Of India Ltd. was fully satisfied on 20 Aug 2024.
- Annual General Meeting
Novartis India Limited last Annual general meeting of members was held on 31 Jul 2024 as per latest MCA records.
- Charges
A charge registered on 21 Jul 1993 via Charge ID 90228667 with Grindlays Bank was fully satisfied on 01 Jul 2024.
- Charges
A charge registered on 17 Aug 1982 via Charge ID 90227632 with Grindlays Bank was fully satisfied on 01 Jul 2024.
- Director Appointment
Falin Ishwarlal Majmudar was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 28 Jun 2024 & has been associated with this company since 10 months 25 days .
- Director Appointment
Chandni Bhupendra Maru was appointed as a Company Secretary was appointed as a Company Secretary on 20 May 2024 & has been associated with this company since 1 year 3 days .
Recent News, Updates & Announcement
- Cipla arm, Novartis enter agreement for Ultibro Breezhaler to treat COPD.
This partnership will enable Cipla arm (Breathe Free Lanka) to facilitate easy access to Ultibro Breezhaler for patients in Sri Lanka to help them alleviate specific debilitating symptoms of... .
Frequently asked questions
What is the Incorporation or founding date of Novartis India Limited?
Novartis India Limited was incorporated on 13 Dec 1947.
What is authorized share capital and paid-up capital of Novartis India Limited?
The authorized share capital of Novartis India Limited is ₹ 32.00 Cr and paid-up capital is ₹ 12.35 Cr.
Who are the current board members & directors of Novartis India Limited?
Currently 8 directors are associated with Novartis India Limited.
- Falin Ishwarlal Majmudar
- Sandra Martyres
- Christopher David Snook
- Sanker Parameswaran
- Gira Jagdeesh Sardesai
- Shilpa Shashank Joshi
- Shilpa Shashank Joshi
- Chandni Bhupendra Maru
What is the registered address of Novartis India Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Novartis India Limited is Inspire Bkc 7Th Floor Kurla Complex East India, Bandra, Maharashtra, 400051.
What is the corporate identification number (CIN) and company number of Novartis India Limited?
The corporate identification number (CIN) of Novartis India Limited is L24200MH1947PLC006104 and the company number is 006104 as per Ministry of Corporate Affairs (MCA).
Is Novartis India Limited registered with any stock exchange in India?
Yes, Novartis India Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): NOVARTIND.
What is the official website of Novartis India Limited?
The Official website of Novartis India Limited is https://www.novartis.in
What has been the recent revenue trend for Novartis India Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Novartis India Limited has risen by 0.88%.
How many employees does Novartis India Limited currently have?
As Per 2023 financial reports, 59 employees are currently employed by Novartis India Limited.
What change has been observed in the net worth of Novartis India Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Novartis India Limited has experienced an upsurge of 12.14%.
When was the last Balance Sheet of Novartis India Limited filed with the ROC?
The most recent Balance Sheet for Novartis India Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Monaz NobleDirector
Manisha GirotraDirector
Dinesh CharakWholetime DirectorJA
Jesus AcebilloDirectorES
Erwin SchillingerDirectorMP
Milan PalejaManaging DirectorPJ
Peter JagerCasual Vacancy DirectorSM
Sanjay MurdeshwarManaging Director
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India